What new HIV treatment did UCSF study involve?

The UCSF study involved experimental immunotherapies combined with an HIV vaccine.

How long did one participant control HIV without medication?

One participant maintained viral control for over 18 months after stopping antiretroviral drugs.

Are these new HIV therapies a cure?

The therapies show promise for long-term control and potential remission, but are not yet a confirmed cure.

Home / Health / HIV Study Offers New Hope for Control, Cure

HIV Study Offers New Hope for Control, Cure

2 Dec, 2025

•

Summary

Ten participants received experimental immunotherapies and an HIV vaccine.
Six participants showed slower viral return after stopping medication.
One individual maintained viral control for over 18 months.

HIV Study Offers New Hope for Control, Cure

Researchers at the University of California, San Francisco (UCSF) have reported exciting findings from a small study investigating novel approaches to HIV control. Ten individuals living with HIV participated in a treatment regimen involving experimental immunotherapies and an HIV vaccine.

Following the immunotherapy, participants ceased their daily antiretroviral medications. A significant outcome was observed as six individuals experienced a delayed and diminished return of the virus over several months. Remarkably, one participant successfully kept the virus suppressed for more than 18 months, a duration far exceeding expectations.